Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Dionyssios Katsaros
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Physiology
Concepts & Ideas
Procedures
Anatomy
Sign-in to see full Profile
Network (preview)
40
Diamandis, Eleftherios
33
Fracchioli, Stefano
30
Massobrio, Marco
20
Rigault de la Longrais, Irene
20
Scorilas, Andreas
18
Yu, Herbert
18
Coukos, George
16
Yousef, George
15
Puopolo, Manuela
14
Zhang, Lin
13
ARISIO, RICCARDO
10
Sismondi, Piero
9
Wiley, Andrew
9
Yang, Nuo
9
Gimotty, Phyllis
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Dionyssios Katsaros (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Gumireddy Kiranmai; Li Anping; Gimotty Phyllis A; Klein-Szanto Andres J; Showe Louise C; Katsaros Dionyssios; Coukos George; Zhang Lin; Huang Qihong
KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer.
Nature cell biology 2009;11(11):1297-304.
-
2009: Pecorelli Sergio; Favalli Giuseppe; Gadducci Angiolo; Katsaros Dionyssios; Panici Pierluigi Benedetti; Carpi Amalia; Scambia Giovanni; Ballardini Michela; Nanni Oriana; Conte PierFranco;
Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4642-8.
-
2009: Collino Federica; Revelli Alberto; Massobrio Marco; Katsaros Dionyssios; Schmitt-Ney Michel; Camussi Giovanni; Bussolati Benedetta
Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population.
Experimental cell research 2009;315(17):2982-94.
-
2009: Pignata Sandro; Ferrandina Gabriella; Scarfone Giovanna; Scollo Paolo; Odicino Franco; Cormio Gennaro; Katsaros Dionyssios; Frigerio Luigi; Mereu Liliana; Ghezzi Fabio; Manzione Luigi; Lauria Rossella; Breda Enrico; Alletti Desiderio Gueli; Ballardini Michela; Vernaglia Alessandra; Sorio Roberto; Tumolo Salvatore; Musso Pietro; Magni Giovanna; Pisano Carmela; Morabito Alessandro
Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
Critical reviews in oncology/hematology 2009;71(3):233-41.
-
2009: Qian Biyun; Katsaros Dionyssios; Lu Lingeng; Preti Mario; Durando Antonio; Arisio Riccardo; Mu Lina; Yu Herbert
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
Breast cancer research and treatment 2009;117(1):131-40.
-
2009: Lu Lingeng; Katsaros Dionyssios; Shaverdashvili Khvaramze; Qian Biyun; Wu Yixing; de la Longrais Irene A Rigault; Preti Mario; Menato Guido; Yu Herbert
Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II.
European journal of cancer (Oxford, England : 1990) 2009;45(12):2212-8.
-
2009: Su Dan; Smith Stephanie M; Preti Mario; Schwartz Peter; Rutherford Thomas J; Menato Guido; Danese Saverio; Ma Shenglin; Yu Herbert; Katsaros Dionyssios
Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.
Cancer 2009;115(11):2453-63.
-
2009: Gadducci Angiolo; Katsaros Dionyssios; Zola Paolo; Scambia Giovanni; Ballardini Michela; Pasquini Enzo; Fertonani Carlo; Maggi Lorenzo; Pecorelli Sergio; Conte Pier Franco;
Weekly low-dose paclitaxel as maintenance treatment in patients with advanced ovarian cancer who had microscopic residual disease at second-look surgery after 6 cycles of paclitaxel/platinum-based chemotherapy: results of an open noncomparative phase 2 multicenter Italian study (After-6 Protocol 2).
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(4):615-9.
-
2009: Mu Lina; Katsaros Dionyssios; Wiley Andrew; Lu Lingeng; de la Longrais Irene A Rigault; Smith Stephanie; Khubchandani Sapna; Sochirca Olga; Arisio Riccardo; Yu Herbert
Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
Breast cancer research and treatment 2009;115(1):151-62.
-
2009: Lissoni A A; Colombo N; Pellegrino A; Parma G; Zola P; Katsaros D; Chiari S; Buda A; Landoni F; Peiretti M; Dell'anna T; Fruscio R; Signorelli M; Grassi R; Floriani I; Fossati R; Torri V; Rulli E
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):660-5.
-
2009: Liang Shun; Yang Nuo; Pan Yue; Deng Shan; Lin Xiaojuan; Yang Xiaojun; Katsaros Dionyssios; Roby Katherine F; Hamilton Thomas C; Connolly Denise C; Coukos George; Zhang Lin
Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.
PloS one 2009;4(1):e4295.
-
2008: Benedetti Panici Pierluigi; Basile Stefano; Maneschi Francesco; Alberto Lissoni Andrea; Signorelli Mauro; Scambia Giovanni; Angioli Roberto; Tateo Saverio; Mangili Giorgia; Katsaros Dionyssios; Garozzo Gaetano; Campagnutta Elio; Donadello Nicoletta; Greggi Stefano; Melpignano Mauro; Raspagliesi Francesco; Ragni Nicola; Cormio Gennaro; Grassi Roberto; Franchi Massimo; Giannarelli Diana; Fossati Roldano; Torri Valter; Amoroso Mariangela; Crocè Clara; Mangioni Costantino
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Journal of the National Cancer Institute 2008;100(23):1707-16.
-
2008: Mu L; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Yu H
TGF-beta1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival.
British journal of cancer 2008;99(8):1357-63.
-
2008: Chanrion Maïa; Negre Vincent; Fontaine Hélène; Salvetat Nicolas; Bibeau Frédéric; Mac Grogan Gaëtan; Mauriac Louis; Katsaros Dionyssios; Molina Franck; Theillet Charles; Darbon Jean-Marie
A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(6):1744-52.
-
2008: Lu Lingeng; Katsaros Dionyssios; Wiley Andrew; de la Longrais Irene A Rigault; Puopolo Manuela; Yu Herbert
Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
Cancer investigation 2008;26(2):185-92.
-
2008: Ferrandina Gabriella; Ludovisi Manuela; Lorusso Domenica; Pignata Sandro; Breda Enrico; Savarese Antonella; Del Medico Pietro; Scaltriti Laura; Katsaros Dionyssios; Priolo Domenico; Scambia Giovanni
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):890-6.
-
2008: Huang Qihong; Gumireddy Kiranmai; Schrier Mariette; le Sage Carlos; Nagel Remco; Nair Suresh; Egan David A; Li Anping; Huang Guanghua; Klein-Szanto Andres J; Gimotty Phyllis A; Katsaros Dionyssios; Coukos George; Zhang Lin; Puré Ellen; Agami Reuven
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.
Nature cell biology 2008;10(2):202-10.
-
2008: Giannakakis Antonis; Sandaltzopoulos Raphael; Greshock Joel; Liang Shun; Huang Jia; Hasegawa Kosei; Li Chunsheng; O'Brien-Jenkins Ann; Katsaros Dionyssios; Weber Barbara L; Simon Celeste; Coukos George; Zhang Lin
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer.
Cancer biology & therapy 2008;7(2):255-64.
-
2008: Buckanovich Ronald J; Facciabene Andrea; Kim Sarah; Benencia Fabian; Sasaroli Dimitra; Balint Klara; Katsaros Dionysios; O'Brien-Jenkins Anne; Gimotty Phyllis A; Coukos George
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.
Nature medicine 2008;14(1):28-36.
-
2008: Pignata Sandro; Ferrandina Gabriella; Scarfone Giovanna; Scollo Paolo; Odicino Franco; Cormio Gennaro; Katsaros Dionyssios; Villa Antonella; Mereu Liliana; Ghezzi Fabio; Manzione Luigi; Lauria Rossella; Breda Enrico; Alletti Desiderio Gueli; Ballardini Michela; Lombardi Alessandra Vernaglia; Sorio Roberto; Mangili Giorgia; Priolo Domenico; Magni Giovanna; Morabito Alessandro
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.
BMC cancer 2008;8():252.
-
2008: Yang Nuo; Huang Jia; Greshock Joel; Liang Shun; Barchetti Andrea; Hasegawa Kosei; Kim Sarah; Giannakakis Antonis; Li Chunsheng; O'Brien-Jenkins Anne; Katsaros Dionyssios; Bützow Ralf; Coukos George; Zhang Lin
Transcriptional regulation of PIK3CA oncogene by NF-kappaB in ovarian cancer microenvironment.
PloS one 2008;3(3):e1758.
-
2007: Zheng Yingye; Katsaros Dionyssios; Shan Shannon J C; de la Longrais Irene Rigault; Porpiglia Mauro; Scorilas Andreas; Kim Nam W; Wolfert Robert L; Simon Iris; Li Lin; Feng Ziding; Diamandis Eleftherios P
A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6984-92.
-
2007: Smith Stephanie; Su Dan; Rigault de la Longrais Irene A; Schwartz Peter; Puopolo Manuela; Rutherford Thomas J; Mor Gil; Yu Herbert; Katsaros Dionyssios
ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(33):5172-9.
-
2007: Lu Lingeng; Katsaros Dionyssios; de la Longrais Irene A Rigault; Sochirca Olga; Yu Herbert
Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
Cancer research 2007;67(21):10117-22.
-
2007: Brokaw Jane; Katsaros Dionyssios; Wiley Andrew; Lu Lingeng; Su Dan; Sochirca Olga; de la Longrais Irene A Rigault; Mayne Susan; Risch Harvey; Yu Herbert
IGF-I in epithelial ovarian cancer and its role in disease progression.
Growth factors (Chur, Switzerland) 2007;25(5):346-54.
-
2007: Beeghly A C; Katsaros D; Wiley A L; Rigault de la Longrais I A; Prescott A T; Chen H; Puopolo M; Rutherford T J; Yu H
IGF-II promoter methylation and ovarian cancer prognosis.
Journal of cancer research and clinical oncology 2007;133(10):713-23.
-
2007: Zhang Lin; Huang Jia; Yang Nuo; Greshock Joel; Liang Shun; Hasegawa Kosei; Giannakakis Antonis; Poulos Nikolaos; O'Brien-Jenkins Ann; Katsaros Dionyssios; Butzow Ralf; Weber Barbara L; Coukos George
Integrative genomic analysis of phosphatidylinositol 3'-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5314-21.
-
2007: Simon Iris; Katsaros Dionyssios; Rigault de la Longrais Irene; Massobrio Marco; Scorilas Andreas; Kim Nam W; Sarno Mark J; Wolfert Robert L; Diamandis Eleftherios P
B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
Gynecologic oncology 2007;106(2):334-41.
-
2007: Buckanovich Ronald J; Sasaroli Dimitra; O'Brien-Jenkins Anne; Botbyl Jeffrey; Hammond Rachel; Katsaros Dionysios; Sandaltzopoulos Raphael; Liotta Lance A; Gimotty Phyllis A; Coukos George
Tumor vascular proteins as biomarkers in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(7):852-61.
-
2007: Shan S J C; Scorilas A; Katsaros D; Diamandis E P
Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.
British journal of cancer 2007;96(2):362-72.
-
2007: Borgoño Carla A; Michael Iacovos P; Shaw Julie L V; Luo Liu-Ying; Ghosh Manik C; Soosaipillai Antoninus; Grass Linda; Katsaros Dionyssios; Diamandis Eleftherios P
Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14.
The Journal of biological chemistry 2007;282(4):2405-22.
-
2007: Gimotty Phyllis A; Zhang Lin; Alagkiozidis Ioannis; Cadungog Mark; Adams Sarah; Chu Christina; Katsaros Dionysios; Coukos George
Immune prognostic factors in ovarian cancer: lessons from translational research.
Disease markers 2007;23(5-6):445-52.
-
2007: Lu Lingeng; Katsaros Dionyssios; Wiley Andrew; Rigault de la Longrais Irene A; Puopolo Manuela; Yu Herbert
Expression of MDR1 in epithelial ovarian cancer and its association with disease progression.
Oncology research 2007;16(8):395-403.
-
2006: Lu Lingeng; Katsaros Dionyssios; Wiley Andrew; Rigault de la Longrais I A; Puopolo Manuela; Schwartz Peter; Yu Herbert
Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
Gynecologic oncology 2006;103(3):990-5.
-
2006: Shan Shannon J C; Scorilas Andreas; Katsaros Dionyssios; Rigault de la Longrais Irene; Massobrio Marco; Diamandis Eleftherios P
Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.
Clinical chemistry 2006;52(10):1879-86.
-
2006: Wiley Andrew; Katsaros Dionyssios; Chen Haigang; Rigault de la Longrais Irene A; Beeghly Alicia; Puopolo Manuela; Singal Rakesh; Zhang Yan; Amoako Agyenim; Zelterman Daniel; Yu Herbert
Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.
Cancer 2006;107(2):299-308.
-
2006: Zhang Lin; Huang Jia; Yang Nuo; Greshock Joel; Megraw Molly S; Giannakakis Antonis; Liang Shun; Naylor Tara L; Barchetti Andrea; Ward Michelle R; Yao George; Medina Angelica; O'brien-Jenkins Ann; Katsaros Dionyssios; Hatzigeorgiou Artemis; Gimotty Phyllis A; Weber Barbara L; Coukos George
microRNAs exhibit high frequency genomic alterations in human cancer.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(24):9136-41.
-
2006: Zhang Lin; Huang Jia; Yang Nuo; Liang Shun; Barchetti Andrea; Giannakakis Antonis; Cadungog Mark G; O'Brien-Jenkins Ann; Massobrio Marco; Roby Katherine F; Katsaros Dionyssios; Gimotty Phyllis; Butzow Ralf; Weber Barbara L; Coukos George
Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma.
Cancer research 2006;66(9):4627-35.
-
2006: Santin Alessandro D; Diamandis Eleftherios P; Bellone Stefania; Marizzoni Moira; Bandiera Elisabetta; Palmieri Michela; Papasakelariou Catherine; Katsaros Dionyssios; Burnett Alexander; Pecorelli Sergio
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
American journal of obstetrics and gynecology 2006;194(5):1296-302.
-
2006: Lu Lingeng; Katsaros Dionyssios; Wiley Andrew; Rigault de la Longrais Irene A; Risch Harvey A; Puopolo Manuela; Yu Herbert
The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1208-14.
-
2006: Beeghly A; Katsaros D; Chen H; Fracchioli S; Zhang Y; Massobrio M; Risch H; Jones B; Yu H
Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival.
Gynecologic oncology 2006;100(2):330-7.
-
2006: Cattel Luigi; Passera Roberto; Katsaros Dyonissios; Medail Maurizio; Milla Paola; Ferrero Anna Maria
Pegylated liposomal doxorubicin and vinorelbine in recurrent ovarian carcinoma: a pharmacokinetic study on alternate administration sequences.
Anticancer research 2006;26(1B):745-50.
-
2006: Fracchioli S; Puopolo M; De La Longrais I A Rigault; Scozzafava M; Bogliatto F; Arisio R; Micheletti L; Katsaros D
Primary "breast-like" cancer of the vulva: a case report and critical review of the literature.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():423-8.
-
2006: Wiley A; Katsaros D; Fracchioli S; Yu H
Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(1):210-8.
-
2006: Pignata Sandro; Ferrandina Gabriella; Scarfone Giovanna; Scollo Paolo; Odicino Franco; Selvaggi Luigi; Katsaros Dionyssios; Frigerio Luigi; Mereu Liliana; Ghezzi Fabio; Manzione Luigi; Lauria Rossella; Breda Enrico; Marforio Giovanna; Ballardini Michela; Lombardi Alessandra Vernaglia; Sorio Roberto; Tumolo Salvatore; Costa Bruno; Magni Giovanna; Perrone Francesco; Favalli Giuseppe;
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study.
Oncology 2006;71(5-6):320-6.
-
2005: Sidiropoulos Michael; Pampalakis Georgios; Sotiropoulou Georgia; Katsaros Dionyssios; Diamandis Eleftherios P
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(6):324-36.
-
2005: Buda Alessandro; Fossati Roldano; Colombo Nicoletta; Fei Francesca; Floriani Irene; Gueli Alletti Desiderio; Katsaros Dionyssios; Landoni Fabio; Lissoni Andrea; Malzoni Carmine; Sartori Enrico; Scollo Paolo; Torri Valter; Zola Paolo; Mangioni Costantino
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4137-45.
-
2005: Zhang Lin; Yang Nuo; Huang Jia; Buckanovich Ronald J; Liang Shun; Barchetti Andrea; Vezzani Cristina; O'Brien-Jenkins Ann; Wang Jennifer; Ward Michelle Renee; Courreges Maria C; Fracchioli Stefano; Medina Angelica; Katsaros Dionyssios; Weber Barbara L; Coukos George
Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth.
Cancer research 2005;65(3):925-32.
-
2005: Berruti A; Bitossi R; Gorzegno G; Bottini A; Generali D; Milani M; Katsaros D; Rigault de la Longrais I A; Bellino R; Donadio M; Ardine M; Bertetto O; Danese S; Sarobba M G; Farris A; Lorusso V; Dogliotti L
Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines.
British journal of cancer 2005;92(4):634-8.
-
2005: Katsaros D; Oletti M V; Rigault de la Longrais I A; Ferrero A; Celano A; Fracchioli S; Donadio M; Passera R; Cattel L; Bumma C
Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):300-6.
-
2005: Cunat S; Rabenoelina F; Daurès J-P; Katsaros D; Sasano H; Miller W R; Maudelonde T; Pujol P
Aromatase expression in ovarian epithelial cancers.
The Journal of steroid biochemistry and molecular biology 2005;93(1):15-24.
-
2005: Berruti Alfredo; Bitossi Raffaella; Bottini Alberto; Bonardi Simone; Donadio Michela; Nigro Cinzia; Bertetto Oscar; Danese Saverio; Bertone Elena; Sarobba Maria Giuseppa; Farris Antonio; Katsaros Dionyssios; Castiglione Federico; Volpe Teresa; Lattuada Sara; Mancarella Sergio; Dogliotti Luigi
Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients.
European journal of cancer (Oxford, England : 1990) 2005;41(2):249-55.
-
2005: Yousef George M; Obiezu Christina V; Luo Liu-Ying; Magklara Angeliki; Borgoño Carla A; Kishi Tadaaki; Memari Nader; Michael lacovos P; Sidiropoulos Michael; Kurlender Lisa; Economopolou Katerina; Kapadia Carl; Komatsu Nahoko; Petraki Constantina; Elliott Marc; Scorilas Andreas; Katsaros Dionyssios; Levesque Michael A; Diamandis Eleftherios P
Human tissue kallikreins: from gene structure to function and clinical applications.
Advances in clinical chemistry 2005;39():11-79.
-
2004: Yousef George M; White Nicole M A; Kurlender Lisa; Michael Iacovos; Memari Nader; Robb John-Desmond; Katsaros Dionyssios; Stephan Carsten; Jung Klaus; Diamandis Eleftherios P
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(5-6):221-7.
-
2004: Katsaros D; Cho W; Singal R; Fracchioli S; Rigault De La Longrais I A; Arisio R; Massobrio M; Smith M; Zheng W; Glass J; Yu H
Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer.
Gynecologic oncology 2004;94(3):685-92.
-
2004: Conejo-Garcia Jose R; Benencia Fabian; Courreges Maria-Cecilia; Kang Eugene; Mohamed-Hadley Alisha; Buckanovich Ronald J; Holtz David O; Jenkins Ann; Na Hana; Zhang Lin; Wagner Daniel S; Katsaros Dionyssios; Caroll Richard; Coukos George
Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A.
Nature medicine 2004;10(9):950-8.
-
2004: Bardin Aurélie; Hoffmann Pascale; Boulle Nathalie; Katsaros Dionyssios; Vignon Françoise; Pujol Pascal; Lazennec Gwendal
Involvement of estrogen receptor beta in ovarian carcinogenesis.
Cancer research 2004;64(16):5861-9.
-
2004: Kurlender Lisa; Yousef George M; Memari Nader; Robb John-Desmond; Michael Iacovos P; Borgoño Carla; Katsaros Dionyssios; Stephan Carsten; Jung Klaus; Diamandis Eleftherios P
Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(3):149-56.
-
2004: Conejo-Garcia Jose R; Benencia Fabian; Courreges Maria C; Gimotty Phyllis A; Khang Eugene; Buckanovich Ronald J; Frauwirth Kenneth A; Zhang Lin; Katsaros Dionyssios; Thompson Craig B; Levine Bruce; Coukos George
Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells.
Cancer research 2004;64(6):2175-82.
-
2004: Porpiglia M; Vicelli R; Durando A; Fracchioli S; Puopolo M; Katsaros D; Bellino R; Benedetto C
[Biologic therapy and epithelial ovarian cancer]
Minerva ginecologica 2004;56(1):91-104.
-
2003: Borgoño Carla A; Grass Linda; Soosaipillai Antoninus; Yousef George M; Petraki Constantina D; Howarth David H C; Fracchioli Stefano; Katsaros Dionyssios; Diamandis Eleftherios P
Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Cancer research 2003;63(24):9032-41.
-
2003: Borgoño Carla A; Fracchioli Stefano; Yousef George M; Rigault de la Longrais Irene A; Luo Liu-Ying; Soosaipillai Antoninus; Puopolo Manuela; Grass Linda; Scorilas Andreas; Diamandis Eleftherios P; Katsaros Dionyssios
Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.
International journal of cancer. Journal international du cancer 2003;106(4):605-10.
-
2003: Yousef George M; Scorilas Andreas; Katsaros Dionyssios; Fracchioli Stefano; Iskander Lisa; Borgono Carla; Rigault de la Longrais Irene A; Puopolo Manuela; Massobrio Marco; Diamandis Eleftherios P
Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3119-26.
-
2003: Maggiora Piera; Lorenzato Annalisa; Fracchioli Stefano; Costa Barbara; Castagnaro Massimo; Arisio Riccardo; Katsaros Dionyssios; Massobrio Marco; Comoglio Paolo M; Flavia Di Renzo Maria
The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness.
Experimental cell research 2003;288(2):382-9.
-
2003: Zhang Lin; Yang Nuo; Katsaros Dionyssios; Huang Wei; Park Jin-Wan; Fracchioli Stefano; Vezzani Cristina; Rigault de la Longrais Irene A; Yao Weijia; Rubin Stephen C; Coukos George
The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma.
Cancer research 2003;63(14):4225-31.
-
2003: Zhang Lin; Yang Nuo; Park Jin-Wan; Katsaros Dionyssios; Fracchioli Stefano; Cao Gaoyuan; O'Brien-Jenkins Ann; Randall Thomas C; Rubin Stephen C; Coukos George
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Cancer research 2003;63(12):3403-12.
-
2003: Fracchioli S; Porpiglia M; Arisio R; Voglino G; Katsaros D
Oral squamous carcinoma in a patient with cervix cancer: use of human papillomavirus analysis to differentiate synchronous versus metastatic tumor.
Gynecologic oncology 2003;89(3):522-5.
-
2003: Scorilas Andreas; Chiang Pui Ming; Katsaros Dionyssios; Yousef George M; Diamandis Eleftherios P
Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors.
Gene 2003;310():79-89.
-
2003: Yousef George M; Polymeris Mary-Ellen; Yacoub George M; Scorilas Andreas; Soosaipillai Antoninus; Popalis Cynthia; Fracchioli Stefano; Katsaros Dionyssios; Diamandis Eleftherios P
Parallel overexpression of seven kallikrein genes in ovarian cancer.
Cancer research 2003;63(9):2223-7.
-
2003: Yousef George M; Fracchioli Stefano; Scorilas Andreas; Borgoño Carla A; Iskander Lisa; Puopolo Manuela; Massobrio Marco; Diamandis Eleftherios P; Katsaros Dionyssios
Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer.
American journal of clinical pathology 2003;119(3):346-55.
-
2003: Diamandis Eleftherios P; Scorilas Andreas; Fracchioli Stefano; Van Gramberen Marleen; De Bruijn Henk; Henrik Alfthan; Soosaipillai Antoninus; Grass Linda; Yousef George M; Stenman Ulf-Hakan; Massobrio Marco; Van Der Zee Ate G J; Vergote Ignace; Katsaros Dionyssios
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1035-43.
-
2003: Kyriakopoulou Lianna G; Yousef George M; Scorilas Andreas; Katsaros Dionyssios; Massobrio Marco; Fracchioli Stefano; Diamandis Eleftherios P
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
Clinical biochemistry 2003;36(2):135-43.
-
2003: Luo Liu-Ying; Katsaros Dionyssios; Scorilas Andreas; Fracchioli Stefano; Bellino Roberto; van Gramberen Marleen; de Bruijn Henk; Henrik Alfthan; Stenman Ulf-Hakan; Massobrio Marco; van der Zee Ate G J; Vergote Ignace; Diamandis Eleftherios P
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Cancer research 2003;63(4):807-11.
-
2003: Zhang Lin; Yang Nuo; Conejo-Garcia Jose-Ramon; Katsaros Dionyssios; Mohamed-Hadley Alisha; Fracchioli Stefano; Schlienger Katia; Toll Alanna; Levine Bruce; Rubin Stephen C; Coukos George
Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):264-72.
-
2003: Zhang Lin; Conejo-Garcia Jose R; Katsaros Dionyssios; Gimotty Phyllis A; Massobrio Marco; Regnani Giorgia; Makrigiannakis Antonis; Gray Heidi; Schlienger Katia; Liebman Michael N; Rubin Stephen C; Coukos George
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.
The New England journal of medicine 2003;348(3):203-13.
-
2002: Hoffman B R; Katsaros D; Scorilas A; Diamandis P; Fracchioli S; Rigault de la Longrais I A; Colgan T; Puopolo M; Giardina G; Massobrio M; Diamandis E P
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker.
British journal of cancer 2002;87(7):763-71.
-
2002: Moll Frederic; Katsaros Dionyssios; Lazennec Gwendal; Hellio Nicolas; Roger Pascal; Giacalone Pierre-Ludovic; Chalbos Dany; Maudelonde Thierry; Rochefort Henri; Pujol Pascal
Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells.
Oncogene 2002;21(7):1097-107.
-
2002: Piccinno R; Puopolo M; Rigault De La Longrais I A; Fracchioli S; Massobrio M; Katsaros D
[Growth factors in epithelial ovarian cancer]
Minerva ginecologica 2002;54(1):33-52.
-
2002: Katsaros D; Yu H; Piccinno R; Puopolo M; Rigault De La Longrais I A; Fracchioli S; Massobrio M
[Expression and prognostic significance in epithelial ovarian cancer]
Minerva ginecologica 2002;54(1):15-24.
-
2001: Yousef G M; Kyriakopoulou L G; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick W J; Richiardi G; Massobrio M; Diamandis E P; Katsaros D
Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Cancer research 2001;61(21):7811-8.
-
2001: Obiezu C V; Scorilas A; Katsaros D; Massobrio M; Yousef G M; Fracchioli S; Rigault de la Longrais I A; Arisio R; Diamandis E P
Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2380-6.
-
2001: Luo L Y; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais I A; Howarth D J; Diamandis E P
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2372-9.
-
2001: Scorilas A; Kyriakopoulou L; Katsaros D; Diamandis E P
Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.
British journal of cancer 2001;85(2):190-8.
-
2001: Magklara A; Scorilas A; Katsaros D; Massobrio M; Yousef G M; Fracchioli S; Danese S; Diamandis E P
The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):806-11.
-
2001: Yousef G M; Magklara A; Chang A; Jung K; Katsaros D; Diamandis E P
Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies.
Cancer research 2001;61(8):3425-31.
-
2001: Katsaros D; Yu H; Levesque M A; Danese S; Genta F; Richiardi G; Fracchioli S; Khosravi M J; Diamandi A; Gordini G; Diamandis E P; Massobrio M
IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival.
European journal of cancer (Oxford, England : 1990) 2001;37(4):478-85.
-
2001: Kim H; Scorilas A; Katsaros D; Yousef G M; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis E P
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
British journal of cancer 2001;84(5):643-50.
-
2000: Bellino R; Cortese P; Danese S; De Sanctis C; Durando A; Genta F; Grio R; Giardina G; Katsaros D; Massobrio M; Richiardi G; Vicelli R
Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients.
Anticancer research 2000;20(6C):4825-8.
-
2000: Levesque M A; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis E P
Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3260-70.
-
1999: Katsaros D; Fracchioli S; Arese P; Enria R; Cassinelli P; Mingrone K; Piccinno R; Rigault de la Longrais I A; Massobrio M
[Chemoresistance in ovarian cancer. State of the art and future prospects]
Minerva ginecologica 1999;51(12):483-99.
-
1999: Katsaros D; Fracchioli S; Arts H J; de Vries E G; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee A G; Suurmeijer A J; Massobrio M
[Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]
Minerva ginecologica 1999;51(12):463-70.
-
1999: Fracchioli S; Katsaros D; Maggiora P; Di Renzo M F; Massobrio M
[Evaluation of Ron and Met proto-oncogene expression in epithelial ovarian tumors]
Minerva ginecologica 1999;51(10):359-64.
-
1999: Arts H J; Katsaros D; de Vries E G; Massobrio M; Genta F; Danese S; Arisio R; Scheper R J; Kool M; Scheffer G L; Willemse P H; van der Zee A G; Suurmeijer A J
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2798-805.
-
1999: Lianidou E S; Levesque M A; Katsaros D; Angelopoulou K; Yu H; Genta F; Arisio R; Massobrio M; Bharaj B; Diamandis E P
Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma.
Anticancer research 1999;19(1B):749-56.
-
1998: Lianidou E S; Angelopoulou K; Katsaros D; Durando A; Massobrio M; Diamandis E P;
Fragment analysis of the p53 gene in ovarian tumors.
Clinical biochemistry 1998;31(7):551-3.
-
1998: Katsaros D; Melegos D N; Diamandis E P
Prostate specific antigen production by breast tumors after induction with oral contraceptives.
Clinical biochemistry 1998;31(4):285-8.
-
1998: Levesque M A; Katsaros D; Yu H; Giai M; Genta F; Roagna R; Ponzone R; Massobrio M; Sismondi P; Diamandis E P
Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients.
International journal of cancer. Journal international du cancer 1998;79(2):147-52.
-
1998: Angelopoulou K; Levesque M A; Katsaros D; Shipman R; Diamandis E P
Exon 5 of the p53 gene is a target for deletions in ovarian cancer.
Clinical chemistry 1998;44(1):72-7.
-
1996: Courjal F; Cuny M; Rodriguez C; Louason G; Speiser P; Katsaros D; Tanner M M; Zeillinger R; Theillet C
DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
British journal of cancer 1996;74(12):1984-9.
-
1996: Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
International journal of cancer. Journal international du cancer 1996;69(4):247-53.
-
1996: Zarghami N; Giai M; Yu H; Roagna R; Ponzone R; Katsaros D; Sismondi P; Diamandis E P
Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients.
British journal of cancer 1996;73(3):386-90.
-
1995: Zarghami N; Katsaros D; Yu H; Diamandis E P
Prognostic value of creatine kinase BB isoenzyme in epithelial ovarian carcinoma.
The Canadian journal of oncology 1995;5(3):401-7.
-
1995: Giai M; Yu H; Roagna R; Ponzone R; Katsaros D; Levesque M A; Diamandis E P
Prostate-specific antigen in serum of women with breast cancer.
British journal of cancer 1995;72(3):728-31.
-
1995: Katsaros D; Theillet C; Zola P; Louason G; Sanfilippo B; Isaia E; Arisio R; Giardina G; Sismondi P
Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients.
Anticancer research 1995;15(4):1501-10.
-
1995: Yu H; Giai M; Diamandis E P; Katsaros D; Sutherland D J; Levesque M A; Roagna R; Ponzone R; Sismondi P
Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.
Cancer research 1995;55(10):2104-10.
-
1995: Levesque M A; Katsaros D; Yu H; Zola P; Sismondi P; Giardina G; Diamandis E P
Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma.
Cancer 1995;75(6):1327-38.
-
1994: Di Renzo M F; Olivero M; Katsaros D; Crepaldi T; Gaglia P; Zola P; Sismondi P; Comoglio P M
Overexpression of the Met/HGF receptor in ovarian cancer.
International journal of cancer. Journal international du cancer 1994;58(5):658-62.
-
1994: Yu H; Diamandis E P; Levesque M; Sismondi P; Zola P; Katsaros D
Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary.
Journal of clinical laboratory analysis 1994;8(4):251-3.
-
1993: Theillet C; Adelaide J; Louason G; Bonnet-Dorion F; Jacquemier J; Adnane J; Longy M; Katsaros D; Sismondi P; Gaudray P
FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers.
Genes, chromosomes & cancer 1993;7(4):219-26.
-
1992: Zola P; Bergamino T; Katsaros D; Ferrero A; Ciancio A; Bellora G; Sismondi P
Phase II trial with 5-fluorouracil and high-dose folinic acid, using new sequential dosing schedule, in pretreated advanced breast cancer patients.
European journal of gynaecological oncology 1992;13(6):527-32.
-
1991: Zola P; Volpe T; Luparia E; Rumore A; Katsaros D; Sismondi P
Localization and management of occult breast lesions.
European journal of gynaecological oncology 1991;12(1):63-8.
-
1990: Volpe T; Katsaros D; Bergamino T; Rumore A; Zola P; Sismondi P
[Occult mammary lesions: preoperative localization. Review of the literature]
Minerva ginecologica 1990;42(10):393-7.
Sign-in to see more
